Status and phase
Conditions
Treatments
About
This study looks at immediate treatment of a cervix with CIN 1 versus regular six-month follow-up with colposcopy and treatment if CIN 1 progresses.
Full description
In women who present with biopsy-proven CIN 1, to compare the management approach of regular colposcopic follow-up and only treating progressive disease using the LEEP, with an approach of immediate treatment using LEEP. The primary outcome is progression to more advanced disease (i.e., CIN 2, CIN 3 or cancer).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Eligible patients will:
Exclusion criteria
any one of the following will be an excluding characteristic:
Primary purpose
Allocation
Interventional model
Masking
415 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal